Dolby Laboratories (DLB) Restructuring Costs (2009 - 2026)

Dolby Laboratories (DLB) has reported Restructuring Costs for 18 consecutive years, with $4.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Restructuring Costs rose 823.03% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2026 stood at $22.7 million (up 68.65% YoY), and the FY2025 full-year result was $15.0 million, up 135.07% from the prior year.
• Restructuring Costs climbed to $4.0 million in Q2 2026 per DLB's latest filing, from $2.2 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $16.7 million in Q2 2023 and bottomed at -$2.5 million in Q1 2024.
• Historically, Restructuring Costs has averaged $4.7 million across 5 years, with a median of $4.4 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Restructuring Costs jumped 2596.31% in 2023, then slumped 7660.61% in 2024.
• Over 5 years, Restructuring Costs stood at -$244000.0 in 2022, then surged by 2596.31% to $6.1 million in 2023, then dropped by 14.37% to $5.2 million in 2024, then soared by 100.65% to $10.5 million in 2025, then plunged by 62.21% to $4.0 million in 2026.
• According to Business Quant data, Restructuring Costs over the past three periods registered $4.0 million, $2.2 million, and $10.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.